Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Over the last 12 months, insiders at Galectin Therapeutics Inc. have bought $24,057 and sold $76,500 worth of Galectin Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Galectin Therapeutics Inc. have bought $49,567 and sold $206,128 worth of stock each year.
Highest buying activity among insiders over the last 12 months: FREEMAN KEVIN D (director) — $13,400. ELDRED KARY (director) — $3,747. Zordani Richard A. Jr. (director) — $3,520.
The last purchase of 2,500 shares for transaction amount of $5,950 was made by FREEMAN KEVIN D (director) on 2024‑06‑20.
2024-06-20 | FREEMAN KEVIN D | director | 2,500 0.0037% | $2.38 | $5,950 | -7.85% | ||
2024-04-30 | Zordani Richard A. Jr. | director | 1,000 0.0016% | $3.52 | $3,520 | -20.00% | ||
2024-04-24 | LEWIS JOEL | President and CEO | 1,000 0.0016% | $3.39 | $3,390 | -10.79% | ||
2024-04-23 | Sale | CZIRR JAMES C | 10 percent owner | 3,677 0.0054% | $3.06 | $11,252 | -10.36% | |
2024-04-22 | Sale | CZIRR JAMES C | 10 percent owner | 21,323 0.0344% | $3.06 | $65,248 | -0.49% | |
2024-04-22 | FREEMAN KEVIN D | director | 2,500 0.0039% | $2.98 | $7,450 | -0.49% | ||
2024-01-16 | ELDRED KARY | director | 500 0.0008% | $1.79 | $893 | +34.07% | ||
2023-07-19 | ELDRED KARY | director | 1,598 0.0028% | $1.79 | $2,854 | +14.33% | ||
2023-02-21 | ELDRED KARY | 1,000 0.0017% | $1.59 | $1,591 | +10.00% | |||
2023-02-16 | LEWIS JOEL | 1,000 0.0017% | $1.52 | $1,520 | +17.33% | |||
2023-01-25 | ELDRED KARY | director | 1,300 0.0022% | $1.11 | $1,443 | +60.00% | ||
2022-11-17 | CALLICUTT JACK W | Chief Financial Officer | 4,000 0.0065% | $1.32 | $5,280 | +22.79% | ||
2022-10-28 | FREEMAN KEVIN D | director | 10,000 0.0171% | $1.41 | $14,100 | +16.55% | ||
2022-07-28 | Zordani Richard A. Jr. | 5,000 0.0085% | $2.50 | $12,500 | -34.68% | |||
2022-07-27 | Sale | 10X Fund, L.P. | 10 percent owner | 10,000 0.0171% | $2.09 | $20,870 | -21.36% | |
2022-07-22 | Sale | CZIRR JAMES C | 10,000 0.019% | $2.09 | $20,870 | -11.89% | ||
2022-05-19 | FREEMAN KEVIN D | 5,000 0.0085% | $1.33 | $6,650 | +23.48% | |||
2022-04-18 | FREEMAN KEVIN D | 5,000 0.0086% | $1.71 | $8,550 | -7.74% | |||
2022-04-04 | Zordani Richard A. Jr. | 5,000 0.0084% | $1.60 | $8,025 | -3.73% | |||
2022-02-02 | Sale | 10X Fund, L.P. | 10 percent owner | 10,000 0.0163% | $2.10 | $21,000 | -27.65% |
CZIRR JAMES C | 5922207 9.9742% | $2.22 | 3 | 30 | <0.0001% | |
FREEMAN KEVIN D | director | 28469 0.1213% | $2.22 | 26 | 0 | +0.09% |
ELDRED KARY | director | 49313 0.0797% | $2.22 | 6 | 0 | +5.2% |
Zordani Richard A. Jr. | 1000 0.0478% | $2.22 | 4 | 0 | <0.0001% | |
LEWIS JOEL | 2000 0.0016% | $2.22 | 7 | 0 | <0.0001% | |
Martin Rod D | director | 9357422 15.1295% | $2.22 | 1 | 4 | <0.0001% |
Uihlein Richard E | 7893191 12.7621% | $2.22 | 6 | 0 | <0.0001% | |
10X Fund, L.P. | 10 percent owner | 6168940 9.9742% | $2.22 | 0 | 38 | |
FIRTEL BURTON C | director | 129000 0.2086% | $2.22 | 3 | 0 | +32.75% |
ROME JERALD K | director | 117344 0.1897% | $2.22 | 2 | 0 | +11.02% |
Greenberg Arthur | director | 109445 0.177% | $2.22 | 6 | 0 | <0.0001% |
TRABER PETER G | President & CEO | 107333 0.1735% | $2.22 | 11 | 2 | +22.8% |
Prelack Steven | director | 87219 0.141% | $2.22 | 0 | 1 | |
OMENN GILBERT S | director | 66769 0.108% | $2.22 | 1 | 2 | <0.0001% |
SMITH DAVID H | director | 63500 0.1027% | $2.22 | 1 | 0 | <0.0001% |
AMELIO GILBERT F | director | 60614 0.098% | $2.22 | 1 | 6 | +7.71% |
CHRISTIAN MILDRED S | director | 27500 0.0445% | $2.22 | 1 | 0 | <0.0001% |
CONAWAY DALE H | director | 22806 0.0369% | $2.22 | 4 | 0 | <0.0001% |
MAULDIN JOHN F | director | 18074 0.0292% | $2.22 | 12 | 0 | +77.12% |
CHRISTOPHER DAVID A | FORMER CFO & TREASURER | 16629 0.0269% | $2.22 | 0 | 2 | |
Rubin Marc | director | 13581 0.022% | $2.22 | 3 | 4 | +24.3% |
MCGAULEY THOMAS | Chief Financial Officer | 10000 0.0162% | $2.22 | 1 | 0 | <0.0001% |
PRESSLER HERMAN PAUL | director | 9500 0.0154% | $2.22 | 1 | 0 | <0.0001% |
CALLICUTT JACK W | Chief Financial Officer | 7614 0.0123% | $2.22 | 4 | 7 | <0.0001% |
PLATT DAVID | Chairman & CEO | 6000 0.0097% | $2.22 | 3 | 1 | +15% |
FOLEY MAUREEN | Chief Operating Officer | 5000 0.0081% | $2.22 | 1 | 0 | +26.27% |
Gourzis James Theophile | director | 2000 0.0032% | $2.22 | 1 | 0 | 0% |
ZUCCONI THEODORE DANIEL | director | 1083 0.0018% | $2.22 | 3 | 1 | +8.35% |
Schwartz Elissa J. | 1000 0.0016% | $2.22 | 1 | 0 | <0.0001% | |
Shlevin Harold H. | Chief Operating Officer | 0 0% | $2.22 | 1 | 10 |
The Vanguard Group | $4.73M | 3.19 | 1.98M | +1.96% | +$90,908.42 | <0.0001 | |
Advisor Group Holdings Inc | $3.02M | 2.04 | 1.26M | +1.1% | +$32,974.50 | 0.01 | |
BlackRock | $1.7M | 1.15 | 712,638 | -0.38% | -$6,484.07 | <0.0001 | |
Geode Capital Management | $1.36M | 0.91 | 567,161 | +10.25% | +$126,086.24 | <0.0001 | |
Geneos Wealth Management Inc | $977,152.00 | 0.66 | 408,850 | -0.92% | -$9,082.00 | 0.05 | |
Sontag Advisory LLC | $952,114.00 | 0.64 | 398,374 | +116.67% | +$512,683.76 | 0.01 | |
Susquehanna International Group | $860,056.00 | 0.58 | 359,856 | +354.82% | +$670,959.17 | <0.01 | |
Atria Wealth Solutions Inc | $513,372.00 | 0.35 | 214,800 | -14.01% | -$83,650.00 | 0.01 | |
Morgan Stanley | $441,412.00 | 0.3 | 184,691 | -0.25% | -$1,089.84 | <0.0001 | |
State Street | $385,842.00 | 0.26 | 161,440 | 0% | +$0 | <0.0001 | |
Cambridge Investment Research Advisors Inc | $290,000.00 | 0.2 | 121,141 | -4.3% | -$13,022.84 | <0.01 | |
Cutter Co Brokerage Inc | $275,947.00 | 0.19 | 115,459 | -1.73% | -$4,849.31 | 0.05 | |
Northern Trust | $241,751.00 | 0.16 | 101,151 | +0.13% | +$308.31 | <0.0001 | |
Qube Research & Technologies | $165,018.00 | 0.11 | 69,045 | -8.44% | -$15,217.17 | <0.0001 | |
LINSCO PRIVATE LEDGER CORP | $131,598.00 | 0.09 | 55,062 | +6.27% | +$7,767.49 | <0.0001 | |
Horizon Kinetics LLC | $128,443.00 | 0.09 | 53,742 | 0% | +$0 | <0.01 | |
Synovus | $114,720.00 | 0.08 | 48,000 | 0% | +$0 | <0.01 | |
D.A. Davidson Companies | $113,895.00 | 0.08 | 47,655 | +11.72% | +$11,949.95 | <0.01 | |
Squarepoint Ops LLC | $114,565.00 | 0.08 | 47,935 | New | +$114,565.00 | <0.0001 | |
Stratos Wealth Partners | $96,676.00 | 0.07 | 40,450 | 0% | +$0 | <0.01 | |
Blair William Co Il | $90,543.00 | 0.06 | 37,884 | 0% | +$0 | <0.0001 | |
Jane Street Capital | $87,916.00 | 0.06 | 36,785 | +8.93% | +$7,208.23 | <0.0001 | |
Traynor Capital Management Inc | $82,950.00 | 0.06 | 34,707 | 0% | +$0 | 0.01 | |
Retirement Guys Formula Llc | $80,619.00 | 0.05 | 33,732 | +56.89% | +$29,234.31 | 0.04 | |
Mariner Llc | $67,823.00 | 0.05 | 28,378 | +160.88% | +$41,824.74 | <0.0001 | |
Millennium Management LLC | $59,944.00 | 0.04 | 25,081 | -9.62% | -$6,381.34 | <0.0001 | |
Vivaldi Capital Management | $72,817.00 | 0.04 | 24,032 | +24.77% | +$14,456.14 | 0.02 | |
Creative Planning | $57,871.00 | 0.04 | 24,214 | 0% | +$0 | <0.0001 | |
Citadel Advisors LLC | $58,605.00 | 0.04 | 24,521 | +249.8% | +$41,851.15 | <0.0001 | |
Beacon Capital Management Llc | $57,133.00 | 0.04 | 23,905 | New | +$57,133.00 | 0.01 | |
Summit Trail Advisors | $47,800.00 | 0.03 | 20,000 | 0% | +$0 | <0.01 | |
Wealth Enhancement Advisory Services LLC | $44,547.00 | 0.03 | 18,639 | 0% | +$0 | <0.0001 | |
Charles Schwab | $41,617.00 | 0.03 | 17,413 | 0% | +$0 | <0.0001 | |
Wedbush Securities Inc | $37,000.00 | 0.03 | 15,498 | 0% | +$0 | <0.01 | |
Bank of America | $35,212.00 | 0.02 | 14,733 | +161.59% | +$21,751.47 | <0.0001 | |
Buckingham Asset Management Llc | $31,629.00 | 0.02 | 13,234 | 0% | +$0 | <0.01 | |
Dynamic Advisor Solutions Llc | $29,653.00 | 0.02 | 12,407 | 0% | +$0 | <0.01 | |
Shepherd Kaplan Krochuk, LLC | $28,680.00 | 0.02 | 12,000 | 0% | +$0 | 0.03 | |
Y Intercept Hong Kong Ltd | $26,625.00 | 0.02 | 11,140 | New | +$26,625.00 | <0.01 | |
Inspire Advisors | $27,062.00 | 0.02 | 11,323 | 0% | +$0 | 0.01 | |
Integrated Wealth Concepts Llc | $23,900.00 | 0.02 | 10,000 | 0% | +$0 | <0.0001 | |
Simplex Trading Llc | $18,000.00 | 0.01 | 7,877 | +13.18% | +$2,095.47 | <0.01 | |
Wells Fargo | $17,338.00 | 0.01 | 7,254 | -4.33% | -$783.96 | <0.0001 | |
Ronald Blue Trust Inc | $16,730.00 | 0.01 | 7,000 | 0% | +$0 | <0.0001 | |
Tower Research Capital | $13,429.00 | 0.01 | 5,619 | -23.73% | -$4,177.59 | <0.0001 | |
Meeder Asset Management Inc | $9,123.00 | 0.01 | 3,817 | 0% | +$0 | <0.01 | |
Sound Income Strategies | $7,122.00 | 0.01 | 2,980 | 0% | +$0 | <0.01 | |
Clearstead Advisors Llc | $9,240.00 | 0.01 | 3,000 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $4,472.00 | <0.01 | 1,871 | +2.63% | +$114.73 | <0.0001 | |
Group One Trading | $1,295.00 | <0.01 | 542 | New | +$1,295.00 | <0.0001 |